-
Article
Open AccessStable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks
Lebrikizumab demonstrated significant improvement versus placebo for measures of skin clearance and patient-reported outcomes at weeks 16 and 52 in patients with moderate-to-severe atopic dermatitis (AD). We r...
-
Article
Open AccessEvaluating Access to Prescription Medications in the Atopic Dermatitis Patient Population in the USA
Despite advances in atopic dermatitis (AD) treatments, many patients face challenges obtaining medications. This study aimed to determine the frequency and causes of insurance coverage delays and denials for A...
-
Article
Open AccessWhen Patient Diversity Informs Formulation: Reimagining Treatment for Seborrheic Dermatitis
Seborrheic dermatitis (SD) impacts a diverse demographic, with treatment effectiveness and suitability varying across hair types and cultural practices. Available shampoo treatments contain surfactants that co...
-
Article
Open AccessUpadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)
Atopic dermatitis (AD) is characterized by intense itch and other symptoms that negatively impact quality of life (QoL). This study evaluates the effect of upadacitinib (an oral selective Janus kinase inhibito...
-
Article
More yeast, more problems?: reevaluating the role of Malassezia in seborrheic dermatitis
Seborrheic dermatitis (SD) is an inflammatory skin disorder and eczema subtype increasingly recognized to be associated with significant physical, psychosocial, and financial burden. The full spectrum of SD, i...
-
Article
Open AccessThe Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
Psoriasis is a chronic inflammatory condition affecting the skin, joints, and several other organ systems with significant disease burden. Bimekizumab is the first monoclonal antibody targeting both interleuki...
-
Article
Evaluation of a patient education platform for seborrheic dermatitis
Seborrheic dermatitis (SD) is a common, burdensome inflammatory skin disorder. Little is known about the identity and quality of videos patients consume on social media to better understand and manage SD. We e...
-
Article
Capturing the Diversity of Dermatology—What’s in a Name?
As research related to skin of color (SOC) in dermatology continues to grow, it is increasingly important to precisely define terminology. The terms ‘SOC’, ‘race’, and ‘ethnicity’ are frequently used to analyz...
-
Article
Atopic Dermatitis Across Shades of Skin
Atopic dermatitis (AD) is a chronic, heterogeneous inflammatory skin disease that is associated with immense patient burden globally. There is increasing appreciation of disparities among patients identified a...
-
Article
Open AccessFinancial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States
Black race is associated with increased atopic dermatitis (AD) severity and healthcare resource utilization. However, the burden of out-of-pocket (OOP) expenses among black individuals with AD is not well unde...
-
Article
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice
Atopic dermatitis (AD) is characterized by a heterogenous longitudinal course with varying severity, flares, and persistence. However, AD course is not routinely assessed in clinical practice or controlled tri...
-
Article
Association of pemphigus and pemphigoid with osteoporosis and pathological fractures
Patients with pemphigus and bullous pemphigoid (BP) have potential risk factors for osteoporosis and/or fractures. To determine whether pemphigus and BP are associated with osteoporosis and fractures in the US...
